Qura Inc., a US developer of a wireless implantable pressure sensor technology and monitoring system, raised a Series A round of funding of undisclosed amount.
InFocus Capital Partners, an investment firm specializing in the identification and commercialization of ophthalmic health care innovations, has provided the funding.
The company intends to use the funds to continue to advance its system.
Led by Douglas Adams, President and Co-founder, Qura develops QSmart, a wireless implantable pressure sensor technology and monitoring system which aims to improve medical and surgical management of glaucoma by providing 24/7 monitoring, pressure event detection and real time intraocular pressure (IOP) updates.
This micro-sized wireless implantable pressure sensor can be programmed to the physician’s exact specifications to monitor and collect the most relevant data concerning IOP changes. The information is then delivered to a handheld device or tablet, allowing physicians to evaluate the effectiveness of current glaucoma treatment for their patients in real-time.